HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Serial assessment of MIBG scintigraphy in a case of DCM with heart failure improved by beta-blocker therapy].

Abstract
We experienced a case of DCM (62-year-old man) improved by beta-blocker (Metoprolol) therapy and studied time course of MIBG scintigraphy. We measured cardiac functions by UCG and 99mTc cardiac pool imaging, and MIBG scintigraphy during 12 months of beta-blocker therapy. In planar images we measured washout rate (WR) in total myocardium and regional washout rate (rWR) in 6 segments of myocardium. Cardiac function improved after 3 months of therapy. The WR did not improve until 6 months, but improved after 9 months (Before: 35.1%, 3 months after: 34.6%, 6 months after: 33.6%, 9 months after: 27.6%, 12 months after: 25.4%). rWR in inferoapical segment first improved at 3 months (Before: 40.1%, 3 months after: 35.1%), whereas rWR in antero-apical segment improved after 6 months and that in anterior segment improved after 9 months. These results suggest that the improvement of cardiac sympathetic nerve function in DCM treated with beta-blocker was not identical in each myocardium region.
AuthorsK Yamamoto, S Asada, T Yabunouchi, R Morozumi, H Kusuoka, T Nishimura
JournalKaku igaku. The Japanese journal of nuclear medicine (Kaku Igaku) Vol. 32 Issue 4 Pg. 413-8 (Apr 1995) ISSN: 0022-7854 [Print] Japan
PMID7776548 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Iodine Radioisotopes
  • Iodobenzenes
  • 3-Iodobenzylguanidine
  • Metoprolol
Topics
  • 3-Iodobenzylguanidine
  • Cardiomyopathy, Dilated (complications, diagnostic imaging, drug therapy)
  • Follow-Up Studies
  • Heart (diagnostic imaging)
  • Heart Failure (complications, diagnostic imaging, drug therapy)
  • Humans
  • Iodine Radioisotopes
  • Iodobenzenes
  • Male
  • Metoprolol (administration & dosage)
  • Middle Aged
  • Monitoring, Physiologic
  • Radionuclide Imaging

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: